Makers laboratories Limited has filed its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The pharmaceutical company submitted the mandatory documentation to BSE on April 6, 2026, fulfilling its regulatory obligations under the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Regulatory Filing Details

The certificate was signed and submitted by Piyush Ajmera, Company Secretary & Compliance Officer of Makers Laboratories Limited. The filing was made through the online system to BSE, with the company trading under scrip code 506919.

Registrar Confirmation Certificate

The submission includes a certificate from MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company's registrar and share transfer agent. The certificate, dated April 3, 2026, was issued by Ashok Shetty, Sr. Vice President-Corporate Registry.

Compliance Confirmations

MUFG Intime India confirmed several key compliance aspects for the quarter:

• Securities received from depository participants for dematerialisation during Q4FY26 were properly confirmed to depositories
• All securities comprised in certificates have been listed on stock exchanges where previously issued securities are listed
• Security certificates received for dematerialisation were confirmed or rejected within prescribed timelines
• Received certificates were mutilated and cancelled after due verification by depository participants
• Depository names were substituted in the register of members as registered owners within required timeframes

About MUFG Intime India

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the registrar and share transfer agent for Makers Laboratories Limited. The company operates from its registered address at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, and holds CIN: U67190MH1999PTC118368.

This quarterly filing demonstrates Makers Laboratories Limited's continued adherence to SEBI's regulatory framework governing depositories and participants, ensuring proper handling of dematerialised securities and maintaining transparency in share transfer processes.

Makers Laboratories Limited has announced strong financial results for the third quarter and nine months ended December 31, 2025, showcasing significant revenue growth and improved profitability across its consolidated operations.

Consolidated Financial Performance

The company delivered impressive consolidated results for Q3FY26, with total income from operations reaching ₹3,566.76 lakhs, marking a substantial 28.8% year-on-year increase from ₹2,768.91 lakhs in Q3FY25. Sequential growth was also positive, with revenue rising 4.4% from ₹3,417.45 lakhs in Q2FY26.

Profitability Analysis

The company's profitability metrics showed remarkable improvement in the quarterly performance. Net profit before tax surged to ₹314.55 lakhs in Q3FY26 from ₹68.36 lakhs in Q3FY25, representing a substantial 360.2% year-on-year growth. Net profit after tax demonstrated even stronger growth, increasing by 733.9% to ₹226.82 lakhs from ₹27.20 lakhs in the corresponding quarter last year.

For the nine-month period, however, the company reported lower profitability compared to the previous year. Net profit after tax stood at ₹430.13 lakhs for nine months FY26, down 53.9% from ₹932.67 lakhs in nine months FY25.

Standalone Operations Performance

The standalone financial results revealed mixed performance across different periods. For Q3FY26, standalone total income from operations was ₹1,270.49 lakhs compared to ₹945.09 lakhs in Q3FY25, showing healthy growth. However, the standalone operations reported a loss before tax of ₹14.15 lakhs in Q3FY26 compared to a loss of ₹84.87 lakhs in Q3FY25.

Earnings Per Share and Capital Structure

The company's earnings per share improved significantly to ₹3.84 in Q3FY26 from negative ₹0.50 in Q3FY25. For the nine-month period, EPS stood at ₹2.13 compared to ₹12.77 in the previous year. The equity share capital remained stable at ₹590.04 lakhs throughout all reported periods.

Comprehensive Income and Reserves

Total comprehensive income for Q3FY26 was ₹225.58 lakhs compared to ₹28.60 lakhs in Q3FY25. For the nine-month period, comprehensive income reached ₹420.84 lakhs versus ₹935.56 lakhs in the corresponding period last year. The company's reserves, excluding revaluation reserves, stood at ₹6,460.55 lakhs as per the previous year's audited balance sheet.